NF-κB signaling: Pros and cons of altering NF-κB as a therapeutic approach

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 114-122

  Egan, Laurence J ^a   Toruner, Murat ^b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Inflammatory bowel disease; Nuclear factor kappa B

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESALAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; CANCER PREVENTION; CELL TYPE; COLON CANCER; COLON CARCINOGENESIS; CONFERENCE PAPER; DISEASE ASSOCIATION; ENTERITIS; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 33749036594     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.009     Document Type: Conference Paper

References (36)

1. SEN, R. & D. BALTIMORE. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
2. SEN, R. & D. BALTIMORE. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47: 921-928.
3. OSBORN, L., S. KUNKEL & G.J. NABEL. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA 86: 2336-2340.
4. ELEWAUT, D. et al. 1999. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163: 1457-1466.
5. LI, N. & M. KARIN. 1998. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95: 13012-13017.
6. HAYDEN, M.S. & S. GHOSH. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
7. ZANDI, E. et al. 1997. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 91: 243-252.
8. KARIN, M., Y. YAMAMOTO & Q.M. WANG. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26.
9. SENFTLEBEN, U. et al. 2001. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499.
10. ROGLER, G. et al. 1998. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369.
11. SCHREIBER, S., S. NIKOLAUS & J. HAMPE. 1998. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477-484.
12. NEURATH, M.F. et al. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2: 998-1004.
13. AUPHAN, N. et al. 1995. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290.
14. WAHL, C. et al. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101: 1163-1174.
15. EGAN, L.J. et al. 1999. Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J. Biol. Chem. 274: 26448-26453.
16. LI, Z.W. et al. 1999. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189: 1839-1845.
17. LI, Q. et al. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284: 321-325.
18. MAKRIS, C. et al. 2000. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell. 5: 969-979.
19. SENFTLEBEN, U. et al. 2001. IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity 14: 217-230.
20. SCHMIDT-SUPPRIAN, M. et al. 2003. Mature T cells depend on signaling through the IKK complex. Immunity 19: 377-389.
21. PASPARAKIS, M., M. SCHMIDT-SUPPRIAN & K. RAJEWSKY. 2002. IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196: 743-752.
22. LI, Z.W. et al. 2003. IKK beta is required for peripheral B cell survival and proliferation. J. Immunol. 170: 4630-4637.
23. ITOH, J. et al. 2001. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 49: 35-41.
24. INA, K. et al. 1999. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J. Immunol. 163: 1081-1090.
25. CHU, W. et al. 2000. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103: 909-918.
26. GRETEN, F.R. et al. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
27. BERIN, M.C. et al. 2002. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell. Microbiol. 4: 635-648.
28. BERIN, M.C. et al. 2001. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am. J. Respir. Cell. Mol. Biol. 24: 382-389.
29. ECKMANN, L. et al. 2000. Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria Salmonella. J. Biol. Chem. 275: 14084-14094.
30. EGAN, L.J. et al. 2004. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc. Natl. Acad. Sci. USA 101: 2452-2457.
31. CHEN, L.W. et al. 2003. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9: 575-581.
32. EGAN, L.J. et al. 2003. Nuclear factor-kappa B activation promotes restitution of wounded intestinal epithelial monolayers. Am. J. Physiol. Cell. Physiol. 285: C1028-C1035.
33. DAJEE, M. et al. 2003. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639-643.
34. BERNSTEIN, C.N. et al. 2002. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm. Bowel Dis. 8: 356-361.
35. JIMI, E. et al. 2004. Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10: 617-624.
36. RUOCCO, M.G. et al. 2005. 1{kappa}B kinase (IKK){beta}, but not lKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201: 1677-1687.